此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Evaluation of the Effect of Smoking on Pyroptosis in Periodontal Pathogenesis

2026年4月28日 更新者:Meryem KOKSALAN、Suleyman Demirel University
This study investigates the impact of smoking on pyroptosis and inflammatory signaling pathways in systemically healthy individuals with various periodontal conditions. The research compares smokers and non-smokers across three clinical categories, resulting in six study groups: Healthy Control, Gingivitis, and Periodontitis. The study specifically evaluates the levels of IL-1beta, IL-18, and NLRP3 through ELISA, and the gene expression of TLR1, TLR4, and TLR6 through RT-PCR, to understand how cigarette smoke modulates innate immune responses in the absence of other systemic diseases.

研究概览

地位

主动,不招人

详细说明

The aim of this research is to clarify the molecular link between tobacco use and pyroptotic cell death pathways in the pathogenesis of periodontal disease. To eliminate systemic bias, only systemically healthy participants are included. The study design consists of 6 distinct groups based on a 2x3 matrix (Smoking Status: Yes/No × Periodontal Status: Healthy/Gingivitis/Periodontitis).

Protein levels of the NLRP3 inflammasome and pro-inflammatory cytokines (IL-1beta, IL-18) are measured in periodontal tissues using the ELISA method. Furthermore, the mRNA expressions of Toll-like receptors (TLR1, TLR4, and TLR6) are analyzed via RT-PCR. These findings will help determine how smoking influences tissue destruction mechanisms specifically through the pyroptosis pathway in different stages of gum disease.

研究类型

观察性的

注册 (实际的)

113

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Isparta
      • Isparta、Isparta、土耳其(türkiye)、32000
        • Suleyman Demirel University, Faculty of Dentistry, Department of Periodontology

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

是的

取样方法

非概率样本

研究人群

The study population consists of individuals who applied to the Department of Periodontology at the Faculty of Dentistry. Participants include systemically healthy volunteers diagnosed with different periodontal conditions (healthy, gingivitis, or periodontitis) and categorized by their smoking status.

描述

Inclusion Criteria:

  • Individuals who voluntarily agreed to participate in the study,
  • Smokers (gingivitis and stage 3/4 generalized periodontitis) and non-smokers (gingivitis and stage 3/4 generalized periodontitis) who applied to the Periodontology Clinical of Suleyman Demirel University Faculty of Dentistry,
  • Individuals without any systemic diseases and without using any medications that affect periodontal health were included.

Exclusion Criteria:

  • Individuals who refuse to participate in the study or who cannot comply with the study protocol,
  • Individuals participating in another clinical trial concurrently, Individuals who have received periodontal treatment within the last 6 months,
  • Individuals who have used medications (antibiotics, anti-inflammatory drugs, etc.) that may affect periodontal parameters within the last 3 months,
  • Individuals with systemic diseases that may affect the periodontium,
  • Individuals with systemic diseases presenting with oral symptoms,
  • Individuals with malignant disease,
  • Pregnant or lactating women,
  • Individuals with psychological or physical disabilities,
  • Individuals with substance abuse,
  • Individuals with severe malocclusion, undergoing orthodontic treatment, using appliances, or using removable dentures,
  • Individuals with acute dental infection or pain (cavities, abscesses, etc.).

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

队列和干预

团体/队列
Healthy Non-Smoker
Systemically healty individulas with clinically healthy periodontal tissues who have never smoked or have not smoked for least 5 years.
Gingivitis Non-Smoker
Systemically healty individulas diagnosed with gingivitis who are non-smokers.
Periodontitis Non-Smoker
Systemically healty individulas diagnosed with Stage III or IV periodontitis who are non-smokers.
Healthy Smoker
Systemically healty individulas with clinically healthy periodontal tissues who have been smoking least 10 cigarettes per day for at least 1 year.
Gingivitis Smoker
Systemically healty individulas with gingivitis who have been smoking least 10 cigarettes per day for at least 1 year.
Periodontitis Smoker
Systemically healty individulas diagnosed with Stage III or IV periodontitis who who have been smoking least 10 cigarettes per day for at least 1 year.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Relative mRNA expression levels of TLR1,TLR4 and TLR6
大体时间:Baseline (At the clinical examination)
Metric:Fold change (2^-ΔΔCt method). Measurement of gene expression levels in gingival tissues using the RT-PCR method.
Baseline (At the clinical examination)
Protein concerntrations of NLRP3, IL-18 and IL-1β
大体时间:Baseline (At the time of clinical examinat
Metric: Picograms per milliliter (pg/mL). Evaluation of protein concentrations in gingival tissue samples using the ELISA method.
Baseline (At the time of clinical examinat

次要结果测量

结果测量
措施说明
大体时间
Periodontal Inflamed Surface Area (PISA)
大体时间:Baseline (At the time of clinical examination)
Metric: square millimeters (mm²). Calculation of the total periodontal inflamed surface area to quantify the inflammatory burden.
Baseline (At the time of clinical examination)
Periodontal Clinical Measurements (PD and CAL)
大体时间:Baseline (At the time of clinical examination)
Metric: millimeters (mm). Measurements of Probing Depth (PD) and Clinical Attachment Level (CAL) using a periodontal probe.
Baseline (At the time of clinical examination)
Periodontal Indices (PI and GI)
大体时间:Baseline (At the time of clinical examination)
Metric: 0-3 numerical scale. Assessment of Plaque Index (PI) and Gingival Index (GI) to evaluate oral hygiene and gingival inflammation.
Baseline (At the time of clinical examination)

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2024年10月15日

初级完成 (实际的)

2025年11月18日

研究完成 (估计的)

2026年6月30日

研究注册日期

首次提交

2026年4月11日

首先提交符合 QC 标准的

2026年4月28日

首次发布 (实际的)

2026年5月1日

研究记录更新

最后更新发布 (实际的)

2026年5月1日

上次提交的符合 QC 标准的更新

2026年4月28日

最后验证

2026年4月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅